Latest / Morning Medical with Dr. Chow / Childhood Abuse Studies, Drug Pricing, AI in Clinics, and Patient Complaints

Transcript

Childhood Abuse Studies, Drug Pricing, AI in Clinics, and Patient Complaints · Morning Medical with Dr. Chow

• 0:00
  Welcome to "Morning Medical with Doctor Chow." I'm Doctor Chi-Ming Chow, your host for today.
• 0:05
  On this podcast, we delve into the most recent medical and health news from around the world,
• 0:11
  all with the help of artificial intelligence.
• 0:14
  Today, we're going to explore a study that reveals some eye-opening findings about
• 0:18
  childhood abuse and its long-term impacts.
• 0:24
  A recent study published in the journal BMJ Open has shed light on the significant and
• 0:29
  long-lasting impacts of childhood verbal and physical abuse.
• 0:32
  According to the research, verbal abuse can leave mental scars just as deep as those caused
• 0:37
  by physical abuse.
• 0:39
  This study is crucial as it suggests that cruel words can have as much of an impact on a
• 0:43
  child's mental health as physical harm.
• 0:47
  The study analyzed data from over 20,000 adults across seven different studies conducted in
• 0:53
  England and Wales.
• 0:55
  Researchers used the Adverse Childhood Experiences tool to evaluate childhood
• 1:00
  experiences and the Warwick-Edinburgh Mental Wellbeing Scale to assess components of adult
• 1:06
  mental health.
• 1:07
  The findings revealed that individuals who experienced physical abuse as children had a
• 1:12
  fifty percent increased risk of reporting low mental health in adulthood.
• 1:18
  Meanwhile, those who experienced verbal abuse were at a sixty percent increased risk of low
• 1:23
  well-being.
• 1:25
  Interestingly, while the prevalence of physical abuse in England and Wales has decreased over
• 1:31
  the decades—from twenty percent for those born between 1950 and 1979 to ten percent for those
• 1:38
  born in or after 2000—verbal abuse has shown an increase.
• 1:43
  This rise in verbal abuse emphasizes the need to raise awareness about the lasting impact of
• 1:49
  spoken abuse, which can often go unnoticed or be underestimated.
• 1:55
  In the United States, data from the Centers for Disease Control and Prevention's Youth Risk
• 1:59
  Behavior Survey highlights a similar issue.
• 2:02
  More than sixty percent of participants reported experiencing emotional abuse, while
• 2:07
  thirty-one point eight percent reported physical abuse.
• 2:11
  The survey used the term 'emotional' rather than 'verbal' abuse, but it covered similar
• 2:16
  behaviors to those examined in the recent study.
• 2:19
  Experts like Doctor Shanta Dube, a professor of epidemiology, point out that verbal abuse often
• 2:26
  gets overshadowed by the focus on physical abuse, even though it can be just as damaging.
• 2:33
  She notes that emotional abuse is frequently tied to verbal abuse, making it crucial to
• 2:39
  recognize and address verbal mistreatment.
• 2:42
  Doctor Andrea Danese, a professor of child and adolescent psychiatry, explains that verbal
• 2:48
  abuse includes a range of behaviors such as blaming, insulting, scolding, criticizing, or
• 2:56
  threatening children.
• 2:57
  He emphasizes that children are concrete thinkers and often take things literally, which
• 3:03
  means harsh words can distort their understanding of themselves and their role in
• 3:07
  the world.
• 3:09
  While the study relies on observational data, meaning it cannot definitively state that
• 3:13
  verbal abuse causes poorer mental health outcomes, it does establish a strong
• 3:17
  connection.
• 3:19
  The large sample size and comprehensive approach add weight to the evidence of verbal
• 3:23
  abuse's impact on mental health.
• 3:26
  The study's authors, including lead researcher Doctor Mark Bellis, stress the importance of
• 3:31
  paying attention to factors that impact long-term mental health.
• 3:36
  As physical abuse awareness has led to its decline, similar efforts are needed to address
• 3:41
  verbal abuse.
• 3:43
  Improving childhood environments can enhance mental well-being and build resilience against
• 3:48
  future challenges.
• 3:50
  Parents and caregivers play a crucial role.
• 3:53
  By fostering emotional regulation and attachment, developing communication skills,
• 3:58
  and modeling positive behaviors, they can create healthier environments for children.
• 4:03
  However, all adults interacting with children should be mindful of the language they use, as
• 4:09
  it can have profound effects.
• 4:12
  Doctor Danese highlights that the goal is not to dramatize past mistakes but to promote
• 4:17
  mindfulness about language and its impact.
• 4:20
  He encourages repairing any harm done with apologies and explanations, fostering a
• 4:26
  cultural shift toward more supportive interactions with children.
• 4:32
  Today, we're diving into the complex issue of rising prescription drug prices in the United
• 4:38
  States.
• 4:39
  A recent listening session hosted by the Federal Trade Commission, along with the
• 4:44
  Departments of Justice, Commerce, and Health and Human Services, highlighted the critical
• 4:49
  role of pharmacy benefit managers, or PBMs, in this ongoing challenge.
• 4:56
  Thomas DeMatteo, chief counsel to Senator Mike Lee from Utah, pointed out that the
• 5:02
  prescription drug marketplace is plagued by a lack of transparency and a confusing web of
• 5:08
  regulations and intermediaries, including PBMs.
• 5:11
  These entities, along with insurance companies, drug wholesalers, and pharmacies, all take a
• 5:18
  cut at various stages in the supply chain, leaving patients feeling the financial pinch.
• 5:24
  Pharmacy benefit managers, while essential in negotiating rebates and discounts from drug
• 5:28
  manufacturers due to their aggregated purchasing power, can also create what DeMatteo
• 5:32
  calls 'perverse incentives.' One such example is the 'rebate trap,' where PBMs may prefer
• 5:38
  higher-priced branded drugs over lower-cost generics because the former generates more
• 5:44
  rebate revenue.
• 5:45
  This system has led to situations where patients are steered away from cost-effective
• 5:50
  options, ultimately increasing their out-of-pocket expenses.
• 5:55
  Nicholas Pottebaum, an adviser to Senate Judiciary Committee chair Senator Chuck
• 6:01
  Grassley from Iowa, noted that PBMs are also affecting patient choice by pushing them
• 6:07
  towards mail-order pharmacies with low reimbursement rates.
• 6:11
  This practice limits access to local pharmacies and reduces competition in the market.
• 6:17
  With three major PBMs controlling about eighty percent of the market, concerns about
• 6:22
  consolidation and its impact on pricing and accessibility are significant.
• 6:28
  This session also brought attention to legislative efforts aimed at increasing
• 6:33
  transparency and fairness in the pharmaceutical industry.
• 6:37
  Senator Grassley has introduced the PBM Transparency Act, a bipartisan bill that aims
• 6:44
  to curb deceptive pricing schemes, prohibit arbitrary clawbacks from pharmacies, and
• 6:51
  require PBMs to disclose their earnings from spread pricing and pharmacy fees to the Federal
• 6:58
  Trade Commission.
• 7:01
  Another legislative effort discussed was the Medication Affordability and Patent Integrity
• 7:05
  Act, co-sponsored by Representative Diana Harshbarger and Senator Maggie Hassan.
• 7:11
  This act targets the manipulation of the drug approval and patent systems by brand-name
• 7:16
  manufacturers.
• 7:17
  They can exploit discrepancies between the Food and Drug Administration and the Patent and
• 7:22
  Trademark Office to extend market exclusivity and block generic drug entry.
• 7:28
  The legislation aims to prevent such practices by requiring manufacturers to provide
• 7:33
  consistent information to both agencies.
• 7:36
  However, not everyone agrees on the issue of patent manipulation.
• 7:41
  Peter-Anthony Pappas, director of intellectual property policy for Senator Thom Tillis, argued
• 7:48
  that 'patent thickets' are not a significant problem in the pharmaceutical industry.
• 7:54
  He emphasized the importance of maintaining a balance that encourages innovation through the
• 7:59
  patent system while ensuring fair competition.
• 8:03
  John Lee, chief counsel for intellectual property at the House Judiciary Committee,
• 8:08
  echoed the need for a balanced approach, acknowledging that while the patent system is
• 8:13
  crucial for fostering innovation, the current status quo is insufficient.
• 8:18
  The committee is exploring various legislative measures to address these issues, including
• 8:24
  improving how courts handle patent disputes and considering 'skinny labeling' for generics to
• 8:30
  enter the market more swiftly.
• 8:33
  In a fascinating look at the intersection of financial incentives and patient care, a recent
• 8:39
  study published in JAMA Network Open has explored the relationship between physicians
• 8:44
  accepting industry payments and patient complaints.
• 8:49
  The research, conducted by Doctor Misop Han and his team at the James Buchanan Brady Urological
• 8:55
  Institute at Johns Hopkins University, analyzed data from nearly seventy-two thousand
• 9:01
  physicians across the United States.
• 9:04
  The findings suggest a significant correlation between higher industry payments and an
• 9:10
  increase in unsolicited patient complaints.
• 9:13
  Specifically, physicians who accepted more than five thousand dollars annually from industry
• 9:17
  sources were more likely to have higher Patient Advocacy Reporting System Index scores, which
• 9:23
  are indicative of more severe or frequent patient complaints.
• 9:27
  Interestingly, about two-thirds of the physicians in this cross-sectional study
• 9:31
  received industry payments, though only a small fraction received amounts over five thousand
• 9:37
  dollars.
• 9:38
  Yet, those who did were significantly more likely to face patient complaints, suggesting
• 9:43
  that financial incentives may influence professional behavior and patient perceptions.
• 9:48
  Doctor Aaron Mitchell from the Memorial Sloan Kettering Cancer Center, in an accompanying
• 9:53
  commentary, highlighted that while the association is potentially concerning, it could
• 9:58
  have various explanations.
• 9:59
  He noted that physicians who see more patients might naturally encounter more complaints, and
• 10:04
  those who prescribe more might attract industry attention.
• 10:08
  However, the study did not control for patient volume, leaving room for further exploration of
• 10:13
  these dynamics.
• 10:15
  Doctor Han emphasized the importance of understanding this connection as industry
• 10:20
  payments are a modifiable risk factor.
• 10:23
  He suggested that health systems and regulatory bodies could use these insights to enhance
• 10:29
  oversight and develop early intervention strategies, such as targeted professionalism
• 10:35
  training for physicians with high Patient Advocacy Reporting System scores.
• 10:40
  The study also noted demographic trends, revealing that male physicians and those in
• 10:45
  nonacademic settings were more likely to receive higher payments.
• 10:49
  These findings underscore the complex interplay between financial conflicts of interest and
• 10:54
  professional conduct in the medical field.
• 10:58
  Despite its insights, the study had limitations, including its observational design
• 11:03
  and reliance on secondary datasets, which could lead to misclassification.
• 11:09
  Future research by Doctor Han's team aims to explore these patterns longitudinally and
• 11:15
  consider the stratification of payment types to better understand their specific impacts on
• 11:20
  patient complaint profiles.
• 11:24
  Let's turn our attention to a topic that's increasingly relevant in today's healthcare
• 11:29
  landscape: the integration of artificial intelligence into clinical practice.
• 11:34
  As we welcome these new technologies, it's crucial to reflect on past experiences,
• 11:39
  particularly the lessons learned from the implementation of electronic medical records.
• 11:45
  The introduction of electronic medical records, or EMRs, was heralded as a way to enhance
• 11:50
  patient care, improve efficiency, and ensure safety.
• 11:55
  However, for many healthcare professionals, the reality didn't quite match the promise.
• 12:01
  Instead of streamlining processes, EMRs often added layers of complexity, leading to
• 12:07
  increased administrative burden and burnout among clinicians.
• 12:11
  The issue was not just the functionality of these systems, but also their lack of alignment
• 12:16
  with the realities of clinical workflows.
• 12:20
  As artificial intelligence begins to make its way into the exam room, we must be vigilant not
• 12:24
  to repeat the mistakes of the past.
• 12:26
  AI holds the potential to transform healthcare by improving diagnostic accuracy, reducing
• 12:32
  administrative tasks, and enhancing patient outcomes.
• 12:36
  Yet, if these tools are developed without the practical insights of clinicians, we risk
• 12:41
  creating solutions that work well in theory but falter in practice.
• 12:45
  A key lesson from the EMR experience is the importance of involving clinicians in the
• 12:50
  development process.
• 12:52
  When frontline healthcare workers are engaged from the start, the resulting tools are not
• 12:57
  only more effective but also more likely to be adopted.
• 13:01
  Clinicians are uniquely positioned to identify workflow inefficiencies, potential safety
• 13:07
  issues, and biases that developers might overlook.
• 13:12
  Their insights are invaluable in shaping AI tools that truly enhance care delivery.
• 13:19
  One successful example of clinician involvement can be seen at a teaching hospital in Canada,
• 13:25
  where developers collaborated with healthcare providers to co-design a clinical communication
• 13:30
  platform called Care Connector.
• 13:32
  Over two years, they implemented thirty-six software updates based on real-world feedback,
• 13:38
  demonstrating how sustained clinician engagement can lead to meaningful improvements
• 13:43
  in healthcare technology.
• 13:45
  For AI to fulfill its potential in healthcare, it must be grounded in the realities of patient
• 13:51
  care.
• 13:52
  This means embedding clinician voices throughout the entire development process, from
• 13:57
  ideation to implementation.
• 13:59
  True co-creation requires more than just token involvement; it demands ongoing, meaningful
• 14:05
  engagement that acknowledges the time and expertise of healthcare professionals.
• 14:11
  Organizations like the American Medical Association are advocating for clinician-led
• 14:15
  innovation, recognizing that the success of AI in healthcare hinges on the active
• 14:22
  participation of those who deliver care.
• 14:25
  By ensuring that clinicians have the authority to shape these tools, we can avoid the pitfalls
• 14:30
  of the past and create technology that truly supports patient care.
• 14:35
  As we embrace the future of AI in medicine, let's remember the hard lessons learned from
• 14:42
  the rollout of electronic medical records.
• 14:44
  Technology that doesn't fit seamlessly into clinical practice can hinder rather than help.
• 14:51
  By prioritizing clinician-centered AI development, we can ensure that these tools
• 14:56
  live up to their promise and genuinely enhance the healthcare experience for both providers
• 15:01
  and patients.
• 15:03
  That's all for today's episode.
• 15:05
  Thank you for joining me on "Morning Medical with Doctor Chow." I hope you'll tune in
• 15:10
  tomorrow for more insights into the world of health and medicine.
• 15:13
  Until then, take care and stay healthy.